Within hepatocellular carcinoma (HCC), studies in vitro have recently shown that inhibition of HSD3B1 with trilostane caused significant inhibition HCC cell clonogenicity and cellular migration. Here, HSD3B1 is linked to hepatocellular carcinoma.